Hgk Asset Management Increased Its Pfizer (PFE) Stake; L & S Advisors Has Cut Eastman Chem Co (EMN) Holding

January 14, 2018 - By Stephen Andrade

Hgk Asset Management Inc increased Pfizer Inc. (PFE) stake by 55.68% reported in 2017Q3 SEC filing. Hgk Asset Management Inc acquired 151,117 shares as Pfizer Inc. (PFE)’s stock declined 3.45%. The Hgk Asset Management Inc holds 422,536 shares with $15.09M value, up from 271,419 last quarter. Pfizer Inc. now has $217.80B valuation. The stock decreased 0.05% or $0.02 during the last trading session, reaching $36.54. About 19.20 million shares traded or 25.61% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since January 14, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

L & S Advisors Inc decreased Eastman Chem Co (EMN) stake by 10.56% reported in 2017Q3 SEC filing. L & S Advisors Inc sold 3,956 shares as Eastman Chem Co (EMN)’s stock declined 2.09%. The L & S Advisors Inc holds 33,495 shares with $3.03 million value, down from 37,451 last quarter. Eastman Chem Co now has $14.00B valuation. The stock decreased 0.07% or $0.07 during the last trading session, reaching $97.43. About 887,430 shares traded. Eastman Chemical Company (NYSE:EMN) has risen 7.60% since January 14, 2017 and is uptrending. It has underperformed by 9.10% the S&P500.




Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Crestwood Advsrs Gru Ltd Company stated it has 0.06% in Pfizer Inc. (NYSE:PFE). Moreover, Dorsey And Whitney has 1.26% invested in Pfizer Inc. (NYSE:PFE). Credit Agricole S A reported 1.48% stake. Tnb Fincl accumulated 0.55% or 93,578 shares. 71,610 were accumulated by Gargoyle Investment Advisor Ltd Liability Company. 180,493 are held by First Bank. Affinity Wealth stated it has 6,354 shares or 0.13% of all its holdings. Camarda Advsr Limited Liability Company invested in 0.99% or 25,733 shares. West Family Investments reported 84,247 shares. Mechanics Savings Bank Tru Department accumulated 1.96% or 230,697 shares. Harvey Inv Co Ltd Liability Corporation holds 34,195 shares or 0.24% of its portfolio. Loeb Partners accumulated 0.14% or 12,700 shares. Moreover, Cutter And Company Brokerage Inc has 0.78% invested in Pfizer Inc. (NYSE:PFE). Schafer Cullen Mngmt has 4.24M shares. Invest Services Inc reported 410,422 shares or 5.61% of all its holdings.

Hgk Asset Management Inc decreased Conocophillips (NYSE:COP) stake by 17,632 shares to 314,322 valued at $15.73 million in 2017Q3. It also reduced Archer Daniels Midl (NYSE:ADM) stake by 39,532 shares and now owns 311,427 shares. Apple Inc. (NASDAQ:AAPL) was reduced too.

Since August 4, 2017, it had 0 insider purchases, and 10 insider sales for $16.36 million activity. MACKENZIE ALEXANDER R sold $249,900 worth of stock or 7,350 shares. OLSON LAURIE J had sold 8,064 shares worth $263,693 on Monday, August 21. $1.34M worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY on Tuesday, September 12. $3.30M worth of Pfizer Inc. (NYSE:PFE) was sold by READ IAN C on Friday, August 4. On Thursday, August 31 DAMELIO FRANK A sold $3.21M worth of Pfizer Inc. (NYSE:PFE) or 94,409 shares. JOHNSON RADY A also sold $296,560 worth of Pfizer Inc. (NYSE:PFE) shares.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 67 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Tuesday, September 13. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by Jefferies on Monday, October 16. The rating was downgraded by Jefferies on Thursday, October 13 to “Hold”. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Thursday, July 13 by Jefferies. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, September 5. Morgan Stanley upgraded it to “Overweight” rating and $38 target in Friday, October 2 report. Argus Research downgraded Pfizer Inc. (NYSE:PFE) on Wednesday, November 2 to “Hold” rating. Cowen & Co maintained it with “Buy” rating and $43.0 target in Monday, September 18 report. As per Monday, June 12, the company rating was maintained by BMO Capital Markets. The stock has “Buy” rating by BMO Capital Markets on Tuesday, November 21.

Analysts await Eastman Chemical Company (NYSE:EMN) to report earnings on January, 25. They expect $1.12 earnings per share, down 25.83% or $0.39 from last year’s $1.51 per share. EMN’s profit will be $160.98M for 21.75 P/E if the $1.12 EPS becomes a reality. After $2.19 actual earnings per share reported by Eastman Chemical Company for the previous quarter, Wall Street now forecasts -48.86% negative EPS growth.

Since August 3, 2017, it had 0 buys, and 3 selling transactions for $934,680 activity. Another trade for 1,400 shares valued at $117,936 was made by COX MARK K on Thursday, August 3. 4,000 shares valued at $337,720 were sold by HORNBAKER RENEE J on Tuesday, August 22. Stuckey Perry sold $479,024 worth of Eastman Chemical Company (NYSE:EMN) on Tuesday, October 31.

L & S Advisors Inc increased Lockheed Martin (NYSE:LMT) stake by 18,100 shares to 22,085 valued at $6.85 million in 2017Q3. It also upped Baidu Inc (Adr) (NASDAQ:BIDU) stake by 3,304 shares and now owns 9,434 shares. Johnson & Johnson (NYSE:JNJ) was raised too.

Among 16 analysts covering Eastman Chemical Company (NYSE:EMN), 9 have Buy rating, 2 Sell and 5 Hold. Therefore 56% are positive. Eastman Chemical Company had 50 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Eastman Chemical Company (NYSE:EMN) earned “Hold” rating by Standpoint Research on Tuesday, January 24. The stock of Eastman Chemical Company (NYSE:EMN) earned “Buy” rating by Nomura on Monday, July 11. The company was maintained on Friday, December 8 by Cowen & Co. RBC Capital Markets initiated the stock with “Outperform” rating in Wednesday, October 14 report. The firm has “Sector Perform” rating given on Monday, October 31 by RBC Capital Markets. The company was maintained on Monday, October 30 by Wells Fargo. Nomura downgraded Eastman Chemical Company (NYSE:EMN) on Tuesday, October 10 to “Neutral” rating. On Monday, October 30 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. On Thursday, July 13 the stock rating was maintained by Cowen & Co with “Buy”. The company was maintained on Wednesday, June 21 by Deutsche Bank.

Investors sentiment increased to 1.18 in Q3 2017. Its up 0.04, from 1.14 in 2017Q2. It is positive, as 32 investors sold EMN shares while 175 reduced holdings. 67 funds opened positions while 178 raised stakes. 115.86 million shares or 0.58% less from 116.54 million shares in 2017Q2 were reported. Natixis invested in 3,716 shares. Synovus Fincl Corporation holds 0.01% or 5,266 shares in its portfolio. Omers Administration Corporation owns 36,200 shares or 0.04% of their US portfolio. Cornerstone Advisors Incorporated holds 0.02% of its portfolio in Eastman Chemical Company (NYSE:EMN) for 344 shares. Omega Advsrs Inc stated it has 464,813 shares or 1.63% of all its holdings. Systematic Financial Mngmt Ltd Partnership has invested 0.01% in Eastman Chemical Company (NYSE:EMN). Quantum Cap Management has invested 2.03% in Eastman Chemical Company (NYSE:EMN). Atwood Palmer reported 1,100 shares. Driehaus Cap Mngmt Ltd Liability Corporation reported 3,415 shares or 0.01% of all its holdings. Ameriprise Financial Inc, a Minnesota-based fund reported 2.93 million shares. Princeton Portfolio Strategies Gru Ltd Com owns 28,066 shares. Amica Pension Fund Board Of Trustees accumulated 9,939 shares. Comerica Bancorp holds 90,055 shares or 0.06% of its portfolio. 316,037 were reported by American Century Cos Inc. Bank Of The West has 26,803 shares for 0.31% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts